Increasing Adoption of Personalized Medicine Boosts HER2 Testing Industry Expansion
As of May 2026, the Human Epidermal Growth Factor Receptor 2 (HER2) Testing Market is undergoing a pivotal expansion. No longer confined to a binary "positive" or "negative" result, the industry is transitioning toward precision subtyping, including the identification of "HER2-low" populations. This shift is driven by the regulatory approval of advanced antibody-drug conjugates (ADCs) like...
0 Commentaires 0 Parts 290 Vue 0 Aperçu
FrendVibe https://frendvibe.com